Elisabeth Leiderman
Director/Board Member presso BLUEBIRD BIO, INC.
Patrimonio netto: 28 488 $ in data 31/03/2024
Relazioni attive
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jason Cole | M | 51 | 8 anni | |
| Robyn Hunter | F | 62 | 11 anni | |
| Gina Consylman | F | 52 | 1 anni | |
| Glenn L. Cooper | M | 71 | 4 anni | |
| Harlan Weisman | M | 71 | 1 anni | |
| Bobby Sandage | M | 70 | 2 anni | |
| Raymond Tesi | M | 68 | 3 anni | |
| Francisco Salva | M | 53 |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 2 anni |
| Noah Beerman | M | 62 | 2 anni | |
| Joshua M. Tarnoff | M | 60 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 7 anni |
| Ramy Ibrahim | M | 49 | - | |
| Alison Finger | F | 60 | 2 anni | |
| Denice Torres | F | 64 | 1 anni | |
| William R. Sellers | M | 63 | 2 anni | |
| Ravichandran Rao | M | - |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 1 anni |
| Matthew Foy | M | - | - | |
| Katherine Edna Breedis | F | 61 | - | |
| Ronald Vigliotta | M | 51 | 5 anni | |
| Chip Baird | M | 52 | 2 anni | |
| Helen C. Fu | F | - | - | |
| Sara Nochur | M | 63 | 2 anni | |
| Kapil Dhingra | M | 64 | 9 anni | |
| Daniel Lynch | M | 65 | 10 anni | |
| Xiao Qin Lu | M | 49 | 5 anni | |
| Michael Rogers | M | 64 | 2 anni | |
| Cynthia Hu | M | 54 | 2 anni | |
| Christine Poon | F | 71 | 2 anni | |
| James Murphy | M | 67 | 1 anni | |
| Wendy Dixon | M | 68 | 8 anni | |
| Peter Thompson | M | 64 | 3 anni | |
| Dale Ritter | M | 73 | 2 anni | |
| William Carson | M | 65 | 2 anni | |
| David Barrett | M | 48 | - | |
| Gary Gemignani | M | 58 | 1 anni | |
| John Johnson | M | 66 | 3 anni | |
| Edgar Braendle | M | - | 3 anni | |
| Evan Renov | M | - | 2 anni | |
| Dorota McKay | F | 42 | - | |
| Rafael Rizo-Patron | M | - |
Nomura Securities, Inc.
| 6 anni |
| Daniel Mamadou Blanco | M | 53 |
Nomura Securities, Inc.
| 3 anni |
| Elizabeth A. Tarka | M | 57 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 2 anni |
| Marcela Maus | M | 48 | - | |
| Gilles Nobécourt | M | 67 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | - |
| Sarah Glickman | F | 54 | 1 anni | |
| Jessica Whitten | F | 48 | 3 anni | |
| Mark T. Battaglini | M | - | - | |
| Anthony Philippakis | M | 48 | 3 anni | |
| Ben Machielse | M | - |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | - |
| Kathleen Wilkinson | F | 52 | 9 anni | |
| Murat Omur | M | 46 |
Nomura Securities, Inc.
| 4 anni |
| Kevin J. Horgan | M | 64 | 1 anni | |
| Diane Jorkasky | M | 72 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 5 anni |
| Sara Nayeem | M | 75 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | - |
| Karin Hehenberger | M | 52 | 2 anni | |
| Jenny Marlowe | M | 47 | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 77 | 77.00% |
| Regno Unito | 23 | 23.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Elisabeth Leiderman
- Contatti personali
